December 8, 2017
On December 8th, 2017, Cannabics Pharmaceuticals Inc. (OTC:CNBX) filed its annual report with the SEC for its fiscal year that ended August 31st, 2017. See the full 10-K filing below.
Be sure to subscribe to one or more of our free e-mail newsletters so that you never miss an important cannabis update. Also, don't forget to connect with The Daily Marijuana Observer via social media on Facebook, Twitter, StockTwits, and Instagram.
Read more articles tagged:
Cannabics Pharmaceuticals Inc.
50 Blue Chip Stocks Worth Less than Half as Much a...
September 19, 2018
5 of Today's Biggest Marijuana Stock Losers -...
September 10, 2018
5 of Today's Biggest Marijuana Stock Gainers -...
September 5, 2018
September 4, 2018
Aphria Partners with Danish Flower Producer
Namaste Announces Medical Cannabis Supply Agreemen...
Aurora Cannabis Closes $200 Million Debt Facility...
August 30, 2018
Former Supreme Pharmaceuticals Director Joins Surna as CEO
August 18, 2017
Surna Inc. Files 10-Q Quarterly Report With the SEC
May 15, 2017
Surna Announces Changes to its Board of Directors
April 18, 2017
Insider Selling at Surna
April 15, 2017
Surna Reports Q4'16 and FY'16 Financials
March 31, 2017
Surna Inc. Signs Contract with ACMPR Applicant Sante Veritas Therapeutic
February 28, 2017